Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


American Vitiligo Research Foundation, Inc.


Address

PO Box 7540
Clearwater, FL 33758 USA

Phone

7274613899

Fax

7274614796

Email Address

vitiligo@avrf.org

Description

The American Vitiligo Research Foundation, Inc., (AVRF), a voluntary 501(c)3 organization, provides public awareness about vitiligo through dedicated work, education and counseling. AVRF seeks to make a difference to those afflicted by this disease, focusing on children and families affected by vitiligo. Vitiligo is a dermatological condition characterized by the appearance of white patches on the skin on different parts of the body as a result of the destruction of the cells that make pigment. AVRF works toward its mission through services such as patient networking and referrals.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.